Cargando…
Coagulation and anticoagulation in COVID-19
COVID-19 has become a pandemic in the United States and worldwide. COVID-19-induced coagulopathy (CIC) is commonly encountered at presentation manifested by considerable elevation of D-dimer and fibrin split products but with modest or no change in activated partial thromboplastin time and prothromb...
Autores principales: | Hadid, Tarik, Kafri, Zyad, Al-Katib, Ayad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543932/ https://www.ncbi.nlm.nih.gov/pubmed/33067035 http://dx.doi.org/10.1016/j.blre.2020.100761 |
Ejemplares similares
-
Thrombotic thrombocytopenic purpura presenting as acute coronary syndrome
por: Mouabbi, Jason Aboudi, et al.
Publicado: (2016) -
Primary Cardiac Lymphoma: Lessons Learned from a Long Survivor
por: Singh, Baljit, et al.
Publicado: (2016) -
Emergence of overt myeloma in a patient with chronic lymphocytic leukemia on ibrutinib therapy
por: Al‐Katib, Ayad M., et al.
Publicado: (2020) -
Composite Lymphoma: Opposite Ends of Spectrum Meet
por: Khan, Uqba, et al.
Publicado: (2017) -
Modulation of deoxycytidine kinase (dCK) and glycogen synthase kinase (GSK-3β) by anti-CD20 (rituximab) and 2-chlorodeoxyadenosine (2-CdA) in human lymphoid malignancies
por: Al-Katib, Ayad M, et al.
Publicado: (2014)